DEFB109D
Beta-defensin 109D
Also known as: D109D_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for DEFB109D in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
87 residues, UniProt reviewed canonical sequence.
>P0DY26|DEFB109D
1 MRLHLLLLIL LLFKILLSPV RGDLGPVEGH CLNLSGVCRR DVCKVVEDQI GACRRRMKCC
61 RAWWILMPIP TPLIMSDYQE PLKPKLKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DEFB109D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DEFB109D as an antibody target. Whether an autoantibody or antibody against DEFB109D could matter depends on whether native DEFB109D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DEFB109D is annotated as secreted, so native DEFB109D circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label DEFB109D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...